Session Schedule
The full and extensive program includes two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research, and other research developments. The ASM program also includes abstracts, debates, and is followed by a two-day trainee and early-career weekend. The theme for the 45th ASM is International Collaboration in Breast Cancer Trials, and we look forward to colleagues joining the meeting.
Introduction to Session
Investigating Novel Breast Cancer Prevention Strategies for Women with BRCA1/2 Pathogenic Variants
Speaker: Professor Geoff Lindeman
Geoff Lindeman
Anthracyclines induce cGAS-STING dependent inflammation and immune checkpoint induction in breast cancer
Speaker: Dr Kienan Savage
Kienan Savage
Topic TBD
Opportunities from the BCT Biobank
Speaker: Dr Nicholas Zdenkowski
Nick Zdenkowski
Morning Tea Break
Topic TBD
Speaker: Professor Andrew Tutt
Andrew Tutt
Lobular Prognostic Biomarkers
Speaker: Associate Professor Amy McCart Reed
Amy McCart Reed
DCIS/LCIS Genomics Update
Speaker: Professor Elinor Sawyer
Elinor Sawyer
Poster/Paper Presentation
Session Close and Lunch Break
Introduction to Session
Pathology of DCIS
Speaker: Professor Sunil Lakhani
Sunil Lakhani
Selecting radiotherapy for DCIS: clinico-pathological data or genomic assays?
Speaker: Professor Elinor Sawyer
Elinor Sawyer
Australian DCISionRT Registry
Speaker: Dr Yvonne Zissiadis
Yvonne Zissiadis
Sparing the nipple in mastectomy patients. How do you decide who is suitable?
Speaker: Professor Elisabeth Elder
Elisabeth Elder
Morning Tea Break
Presentation of John Collins Medal
Is there anyone (medically fit) who shouldn't be offered immediate breast reconstruction after mastectomy for breast cancer?
Speaker: Professor Andrew Spillane
Andrew Spillane
Topic TBD
Speaker: Mr Peter Barry
Peter Barry
Topic TBD
Speaker: Dr Melissa Bochner
Melissa Bochner